Trulieve Cannabis (TRLV) Could Be 43% Undervalued After $65 Million Debt Repayment

Trulieve Cannabis (TRLV) has wiped out about US$65 million of mortgage notes tied to its Jefferson County, Florida cultivation site, trimming total debt to roughly US$225 million and reshaping its capital structure for investors.

At a share price of US$10.30, Trulieve Cannabis has posted an 18.39% year to date share price return and a 27.63% total shareholder return over the past 12 months. The recent 3.31% 1 day move and 17.18% 90 day share price return suggest that momentum has picked up again after an 11.21% 30 day pullback.

See how Trulieve Cannabis compares on balance sheet strength by reviewing the hand picked list of solid balance sheet and fundamentals (25 results) alongside this latest debt reduction move.

Debt is lighter, momentum has resurfaced and the business still reports losses. At this price, does Trulieve Cannabis offer enough upside potential to justify the risk you are taking?

Most Popular Narrative: 43% Undervalued

Against a last close of $10.30, the most followed narrative for Trulieve Cannabis points to a fair value of $18.18. The debate therefore shifts from whether it is cheap to what needs to go right to close that gap.

A strong cash position of US$353 million against US$290 million in debt and positive free cash flow of US$42 million in the quarter provide room to fund new stores, production upgrades and possible acquisitions, which can influence future revenue and earnings power.

See why 7 investors see Trulieve Cannabis as 43% undervalued.

Result: Fair Value of $18.18 (UNDERVALUED)

Still, this Trulieve Cannabis story can change if federal rescheduling delivers less tax relief than hoped or if new state programs attract fewer patients than analysts assume.

Find out about the key risks to this Trulieve Cannabis narrative.

Next Steps

Sentiment on Trulieve Cannabis is mixed, with both risks and potential rewards in play. Act while the data is fresh and shape your own view by reviewing the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Trulieve Cannabis?

If Trulieve Cannabis has your attention, do not stop there. Broader context from other opportunities can sharpen your thinking and help you position confidently.

• Target resilient balance sheets and steady fundamentals by scanning the list of solid balance sheet and fundamentals (25 results) for companies that may better fit your risk tolerance.
• Hunt for mispriced opportunities by reviewing the 33 high quality undervalued stocks that combine quality metrics with potentially attractive entry points.
• Spot lesser known businesses with strong foundations by working through the 20 high quality undiscovered gems before other investors pay attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com